OR WAIT null SECS
Kevin Gopal is Pharmaceutical Executive's international correspondent, covering pharma and regulatory issues around the word. He is also a political columnist for North West Business Insider, one of the UK's leading regional business magazines. He started his career as a journalist at SiYu, the UK's Chinese community magazine, before joining the PE staff.
Geneva-The usually quiet International Federation of Pharmaceutical Manufacturers Associations (IFPMA) leapt to Pfizer’s defense after Oxfam International criticized the US company about access to medicines in the developing world.